Avid Bioservices Statistics
Total Valuation
CDMO has a market cap or net worth of $786.75 million. The enterprise value is $958.65 million.
Important Dates
The last earnings date was Tuesday, December 10, 2024, after market close.
| Earnings Date | Dec 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CDMO has 63.96 million shares outstanding. The number of shares has increased by 1.33% in one year.
| Current Share Class | 63.96M |
| Shares Outstanding | 63.96M |
| Shares Change (YoY) | +1.33% |
| Shares Change (QoQ) | +0.31% |
| Owned by Insiders (%) | 1.38% |
| Owned by Institutions (%) | 88.98% |
| Float | 50.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.20 |
| Forward PS | 4.36 |
| PB Ratio | 17.56 |
| P/TBV Ratio | 17.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 149.63 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.30, with a Debt / Equity ratio of 4.62.
| Current Ratio | 1.30 |
| Quick Ratio | 0.88 |
| Debt / Equity | 4.62 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.30 |
Financial Efficiency
Return on equity (ROE) is -133.29% and return on invested capital (ROIC) is -4.03%.
| Return on Equity (ROE) | -133.29% |
| Return on Assets (ROA) | -3.27% |
| Return on Capital (ROIC) | -4.03% |
| Revenue Per Employee | $405,512 |
| Profits Per Employee | -$409,838 |
| Employee Count | 371 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 4.17 |
Taxes
In the past 12 months, CDMO has paid $116.82 million in taxes.
| Income Tax | 116.82M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +74.47% in the last 52 weeks. The beta is 1.41, so CDMO's price volatility has been higher than the market average.
| Beta (5Y) | 1.41 |
| 52-Week Price Change | +74.47% |
| 50-Day Moving Average | 11.50 |
| 200-Day Moving Average | 9.42 |
| Relative Strength Index (RSI) | 62.07 |
| Average Volume (20 Days) | 1,237,557 |
Short Selling Information
The latest short interest is 11.64 million, so 18.20% of the outstanding shares have been sold short.
| Short Interest | 11.64M |
| Short Previous Month | 11.72M |
| Short % of Shares Out | 18.20% |
| Short % of Float | 23.00% |
| Short Ratio (days to cover) | 3.79 |
Income Statement
In the last 12 months, CDMO had revenue of $150.45 million and -$152.05 million in losses. Loss per share was -$2.39.
| Revenue | 150.45M |
| Gross Profit | 11.55M |
| Operating Income | -20.38M |
| Pretax Income | -26.93M |
| Net Income | -152.05M |
| EBITDA | -7.91M |
| EBIT | -20.38M |
| Loss Per Share | -$2.39 |
Full Income StatementBalance Sheet
The company has $35.12 million in cash and $207.02 million in debt, giving a net cash position of -$171.91 million or -$2.69 per share.
| Cash & Cash Equivalents | 35.12M |
| Total Debt | 207.02M |
| Net Cash | -171.91M |
| Net Cash Per Share | -$2.69 |
| Equity (Book Value) | 44.81M |
| Book Value Per Share | 0.70 |
| Working Capital | 22.35M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $5.26 million and capital expenditures -$14.94 million, giving a free cash flow of -$9.68 million.
| Operating Cash Flow | 5.26M |
| Capital Expenditures | -14.94M |
| Free Cash Flow | -9.68M |
| FCF Per Share | -$0.15 |
Full Cash Flow StatementMargins
Gross margin is 7.68%, with operating and profit margins of -13.55% and -101.07%.
| Gross Margin | 7.68% |
| Operating Margin | -13.55% |
| Pretax Margin | -23.42% |
| Profit Margin | -101.07% |
| EBITDA Margin | -5.26% |
| EBIT Margin | -13.55% |
| FCF Margin | n/a |
Dividends & Yields
CDMO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.33% |
| Shareholder Yield | -1.33% |
| Earnings Yield | -19.33% |
| FCF Yield | -1.23% |
Dividend DetailsAnalyst Forecast
The average price target for CDMO is $12.25, which is -0.41% lower than the current price. The consensus rating is "Hold".
| Price Target | $12.25 |
| Price Target Difference | -0.41% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 22.48% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on July 10, 2017. It was a reverse split with a ratio of 0.1428571:1.
| Last Split Date | Jul 10, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.1428571:1 |
Scores
CDMO has an Altman Z-Score of -1.14 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.14 |
| Piotroski F-Score | 4 |